Taking Berberine With Ketamine: What to Know
Berberine — Herbal alkaloid (glucose/lipid metabolism)
Verdict at Tovani Health
Compatible; CYP3A4 inhibition is the consideration, similar profile to mild prescription inhibitors.
Berberine and ketamine are compatible. The marketing hype around berberine as nature's Ozempic obscures a real pharmacology point: berberine is a moderate CYP3A4 inhibitor and can theoretically raise ketamine plasma levels. The effect is smaller than ritonavir or clarithromycin but worth disclosing.
If you take Berberine regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or modest dose adjustment. This page covers the brief pharmacologic context and what we do at intake.
How Berberine interacts with ketamine
Berberine is an isoquinoline alkaloid that activates AMP-activated protein kinase, with modest glucose-lowering and lipid-lowering effects. Inhibits CYP3A4 and P-glycoprotein in vitro at therapeutic concentrations.
What we do at intake
Disclose dose and brand. Tell us about any other CYP3A4 modulators you take.
Bottom line
Berberine and ketamine are compatible. The marketing hype around berberine as nature's Ozempic obscures a real pharmacology point: berberine is a moderate CYP3A4 inhibitor and can theoretically raise ketamine plasma levels. The effect is smaller than ritonavir or clarithromycin but worth disclosing.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Berberine at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Clinical Pharmacokinetics. 2016. PMID: 27028535
- Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib. Adiwidjaja J, Boddy AV, McLachlan AJ. European Journal of Clinical Pharmacology. 2022. PMID: 35048143
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 17, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.